The alternatives
JRNYS scores 53/100 (grade C, ranked #451) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to JRNYS's 53, and our JRNYS vs CoreAge Rx comparison sets the two out factor by factor.
Evernow is a women's-focused, menopause-centered telehealth platform that prescribes branded GLP-1 weight loss medications including Ozempic, Wegovy, Zepbound, and Mounjaro via US-licensed clinicians.
Evernow matches JRNYS at 53/100; our Evernow review in full has the pricing conditions and the caveats in detail.
Maven Clinic is a virtual women's and family health platform (fertility, maternity, menopause, pediatrics) used by 2,300+ employers that also runs a dedicated GLP-1 Care program.
Maven Clinic matches JRNYS at 53/100; our full write-up on Maven Clinic has the pricing conditions and the caveats in detail.
ElleS (ElleS Inc.) is a comprehensive compounded telehealth service.
ElleS matches JRNYS at 53/100; the full ElleS review has the pricing conditions and the caveats in detail.
MDLive (an Evernorth/Cigna company) is a large telehealth provider offering urgent care, primary care, dermatology and behavioral health.
MDLive matches JRNYS at 53/100; our full write-up on MDLive has the pricing conditions and the caveats in detail.
Eclipse Medical Wellness is a Colorado-only, clinician-led telehealth weight-loss program.
Eclipse Medical Wellness matches JRNYS at 53/100; our Eclipse Medical Wellness review in full has the pricing conditions and the caveats in detail.
Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work.
Meto matches JRNYS at 53/100; the full Meto review has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.